From Innovation to Access
HIV Resistance Testing Where It Matters Most

Convened by

Alex John Ntamatungiro
Early-Career Fellow 2025–2026

Details

Venue & accessibility infos: Meridian Hall, Collegium Helveticum

This event is open to the public, free of charge, and no registration needed.

Despite major advances in HIV treatment, access to genotypic resistance testing remains uneven and is often unavailable where the burden of disease is greatest. This symposium brings together researchers, clinicians, technologists, and policy experts to examine why genomic HIV resistance testing fails to reach those who need it most and what can be done to change that.

While sequencing technologies have become faster, more precise, and increasingly affordable, structural inequities, fragmented policy frameworks, limited laboratory infrastructure, and funding constraints continue to hinder their integration into routine care in low- and resource-constrained settings.

Through interdisciplinary perspectives, the program moves from diagnosing the problem to identifying actionable solutions. Presentations address structural, technological, and policy barriers, as well as real-world experiences implementing sequencing-based resistance testing in clinical diagnostics. Further contributions examine the constraints that shape the deployment of emerging technologies and discuss legal and economic frameworks needed to ensure equitable access.

A moderated roundtable discussion will foster dialogue on implementation pathways, sustainable funding models, and cross-sector partnerships capable of bridging the gap between innovation and real-world impact.

By linking scientific advances with policy reform and the realities of health systems, the symposium aims to outline a practical path forward and explore how genomic innovation can become an accessible and scalable tool that strengthens HIV care globally and helps reduce inequalities in treatment outcomes.

Program